Efficacy of Low-residue Full Nutritive Formula Powder in Bowel Preparation for Colonoscopy
NCT ID: NCT06514989
Last Updated: 2025-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
757 participants
INTERVENTIONAL
2024-07-01
2025-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Different Bowel Preparations in Magnetically Controlled Capsule Endoscopy
NCT06313242
a Low-residue Diet for Bowel Preparation
NCT03943758
Improving Outcomes for Patients Requiring Oral Bowel Preparation for Colonoscopy
NCT00693290
Diet Selection Pre-Colonoscopy: Comparison Between Clear, Low-residue and Regular Diet
NCT03681444
Comparison Between 3-L and 4-L Polyethylene Glycol in Bowel Preparation
NCT03356015
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low-residue nutrition formula podwer combined with 2 liters of polyethylene glycol
Low-residue full nutrition formula podwer
The day before the colonoscopy, subjects were given a low-residue full nutrition formula podwer instead of a traditional self-prepared low-residue diet. Subjects were given 6 packs (60g/pack) pre-packaged FNFP and asked to use the FNFP according to individual needs. The 2 liters of polyethylene glycol solution is taken in split dosing, with 1 liter taken at 8pm the day before the colonoscopy and 1 liter taken 3-5 hours before the colonoscopy.
Self-prepared low-residue diet combined with 3 liters of polyethylene glycol
Self-prepared low-residue diet
Subjects in the self-prepared Low-residue diet group were instructed to follow and prepare an Low-residue diet in the day prior to colonoscopy. The 3 liters of polyethylene glycol solution is taken in split dosing, with 1 liter taken at 8pm the day before the colonoscopy and 2 liter taken 4-6 hours before the colonoscopy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-residue full nutrition formula podwer
The day before the colonoscopy, subjects were given a low-residue full nutrition formula podwer instead of a traditional self-prepared low-residue diet. Subjects were given 6 packs (60g/pack) pre-packaged FNFP and asked to use the FNFP according to individual needs. The 2 liters of polyethylene glycol solution is taken in split dosing, with 1 liter taken at 8pm the day before the colonoscopy and 1 liter taken 3-5 hours before the colonoscopy.
Self-prepared low-residue diet
Subjects in the self-prepared Low-residue diet group were instructed to follow and prepare an Low-residue diet in the day prior to colonoscopy. The 3 liters of polyethylene glycol solution is taken in split dosing, with 1 liter taken at 8pm the day before the colonoscopy and 2 liter taken 4-6 hours before the colonoscopy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* a history of abdominal or pelvic surgery, BMI \> 28 or BMI \< 18.5, inflammatory bowel disease, constipation (less than 3 bowel movements in the past week, with strenuous bowel movements, hard stool, small volume), or intestinal obstruction.
* imaging and laboratory tests are highly suspicious of colorectal cancer or warning signs and symptoms of colorectal cancer: blood in the stool, black stool, unexplained anemia and significant weight loss, abdominal mass, and positive digital rectal examination.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhaoshen Li
Director of the Department of Gastroenterology, the First Affiliated Hospital of Naval Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Zhaoshen, PhD
Role: STUDY_CHAIR
Department of Gastroenterology, Changhai Hospital, Navy Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lu'an People's Hospital
Lu'an, Anhui, China
PLA 909 Hospital
Quanzhou, Fujian, China
PLA 909 Hospital
Zhangzhou, Fujian, China
Huizhou Central People's Hospital
Huizhou, Guangdong, China
Jiangmen Central Hospital
Jiangmen, Guangdong, China
Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The First Affiliated Hospital of Hebei North University
Zhangjiakou, Hebei, China
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Nanjin, Jiangsu, China
Jiangsu Province Hospital
Nanjing, Jiangsu, China
Nanjing Gulou Hospital
Nanjing, Jiangsu, China
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, China
Jiangsu Subei People's Hospital
Yangzhou, Jiangsu, China
Ganzhou People's Hospital
Ganzhou, Jiangxi, China
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
the central hospital of Dalian
Dalian, Liaoning, China
Northern Theater General Hospital
Shenyang, Liaoning, China
Shengli Oilfield Central Hospital
Dongying, Shandong, China
Shandong Provincial Hospital
Jinan, Shandong, China
Changhai Hospital, Naval Medical University
Shanghai, Shanghai Municipality, China
Shanghai East Hospital
Shanghai, Shanghai Municipality, China
Ankang Central Hospital
Ankang, Shanxi, China
Yibin Second People's Hospital
Yibin, Sichuan, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
East China Hospital, Fudan University
Shanghai, , China
Shanghai Seventh People's Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FNFP2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.